With this announcement, AOK Bayern publishes, for reasons of transparency, all contracts concluded within the framework of the open house procedures for drug discount contracts pursuant to § 130a(8) SGB V and § 130a(8)(c) SGB V in the period from 16.09.2024 to 15.10.2024. AOK Bayern intends to conclude non-exclusive rebate agreements with all interested pharmaceutical companies on the active substances mentioned in the respective procedure pursuant to § 130a(8) SGB V or § 130a(8)(c) SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility requirements listed below the conclusion of identical and non-individually negotiable discount agreements. A contract can be concluded at any time during the term. Contracts may be terminated with a notice period of one month to the end of the month. Upon entry into force of a rebate agreement for medicinal products with the active substance subject to the contract concluded by means of a nationwide or country-specific rebate agreement concluded in an open procedure, the open-house agreements automatically cease to apply for the corresponding term. A contract is concluded with all interested pharmaceutical companies that prove their suitability by means of a completed and signed self-declaration of reliability. Details can be found in the contract notice for the respective open house procedure in the Official Journal of the European Union. Contracts concluded between 16.09.2024 and 15.10.2024: 1. Botulinum toxin type A, finished product name (Dysport (R)/Dysline (R)): EurimPharm Arzneimittel GmbH, Saaldorf-Suhlheim 2. Mesalazine: Kohlpharma GmbH, Merzig; axicorp Pharma B.V., EC Den Haag, axicorp Pharma GmbH, Friedrichsdorf, CC Pharma GmbH, Densborn; Abacus Medicine A/S, Copenhagen, Denmark 3. Pomalidomide: Accord Healthcare S.L.U., Munich 4. Rituximab: 1 4 U Pharma GmbH, Densborn 5. Rivaroxaban film-coated tablet (excluding 2.5 mg): Abacus Medicine A/S, Copenhagen, Denmark 6. Testosterone: Galenpharma GmbH, Kiel 7. Abatacept: Medicopharm AG, Nußdorf am Inn; Originalis B.V., Amsterdam_Netherlands 8. Aripiprazole in the dosage form depot suspension for injection: EurimPharm Arzneimittel GmbH, Saaldorf-Surheim 9. dabigatran etexilate: Abacus Medicine A/S, Copenhagen, Denmark; Viatris Healthcare GmbH, Bad Homburg 10. Emtricitabine: Rilpivirine, Tenofovir disoproxil, kohlpharma GmbH, Merzig; EMRA-MED Arzneimittel GmbH, Trittau 11. Epinephrine: Originalis B.V., Amsterdam, Netherlands 12. Etanercept: Abacus Medicine A/S, Copenhagen, Denmark 13. Infliximab: Abacus Medicine A/S, Copenhagen, Denmark; ACA Müller ADAG Pharma AG, Gottmadingen; EurimPharm Arzneimittel GmbH, Saaldorf-Surheim; kohlpharma GmbH, Merzig; Originalis B.V., Amsterdam, Netherlands 14. Naproxen: AbZ Pharm GmbH, Ulm 15. Nitisinone: Abacus Medicine A/S, Copenhagen, Denmark 16. raltegravir,: Abacus Medicine A/S, Copenhagen, Denmark; EurimPharm Arzneimittel GmbH, Saaldorf-Surheim; Originalis B.V., Amsterdam, Netherlands; 101 Carefarm GmbH, Leverkusen; axicorp Pharma B.V., EC The Hague; Orifarm GmbH, Leverkusen 17. Rasagiline: Ascend GmbH, Frankfurt am Main; Abacus Medicine A/S, Copenhagen, Denmark; AbZ-Pharma GmbH, Ulm; betapharm Arzneimittel GmbH, Augsburg; Originalis B.V., Amsterdam, Netherlands; ratiopharm GmbH, Ulm; Teva GmbH, Ulm 18. Ribociclib: ACA Müller ADAG Pharma AG, Gottmadingen; 101 Carefarm GmbH, Leverkusen; axicorp Pharma GmbH, Friedrichsdorf; Orifarm GmbH, Leverkusen 19. Sarilumab: Abacus Medicine A/S, Copenhagen, Denmark 20. Somatropin: 1 4 U Pharma GmbH, Densborn 21. Sorafenib: betapharm Arzneimittel GmbH, Augsburg; ratiopharm GmbH, Ulm 22. Teriparatide: ACA Müller ADAG Pharma AG, Gottmadingen 23. ustekinumab: CC Pharma GmbH, Densborn 24. Febuxostat: 1 A Pharma GmbH, Holzkirchen; Aliud Pharma GmbH, Laichingen; Stadapharm GmbH, Bad Vilbel; Zentiva Pharma GmbH, Berlin 25. Flecainide: Micro Labs GmbH, Frankfurt am Main 26. Golimumab: Orifarm GmbH, Leverkusen 27. Allergen extracts from grass pollen for sublingual use, finished product name: Oralair (R): EMRA-MED Arzneimittel GmbH, Trittau 28. Lacosamide: excluding pharmaceutical form film-coated tablets, Aliud Pharma GmbH, Laichingen; neuraxpharm Arzenimittel GmbH, Langenfeld; Stadapharm GmbH, Bad Vilbel 29. Lanthanum(III) carbonate: Takeda GmbH, Constance 30. Lisdexamfetamine: Aliud Pharma GmbH, Laichingen; Stadapharm GmbH, Bad Vilbel; Takeda GmbH, Constance 31. Pegfilgrastim: Allomedic GmbH, Cologne 32. Pomalidomide: Zentiva Pharma GmbH, Berlin 33. Telmisartan: 1 A Pharma GmbH, Holzkirchen; TAD Pharma GmbH, Cuxhaven; Aliud Pharma GmbH, Laichingen; Glenmark Arzneimittel GmbH, Gröbenzell; Hexal AG, Holzkirchen; Micro Labs GmbH, Frankfurt am Main; Stadapharm GmbH, Bad Vilbel; Zentiva Pharma GmbH, Berlin 34. Timolol and latanoprost: Aliud Pharma GmbH, Laichingen; Stadapharm GmbH, Bad Vilbel; Viatris Healthcare GmbH, Bad Homburg 35. Tolvaptan: CC Pharma GmbH, Densborn
Text automatically translated in your browsing language
Automatically translated
